Evaluation of the impact of CXCR4, ССR10 chemokine receptor expression in tumor tissue on relapse free survival in colon cancer patients
https://doi.org/10.18027/2224-5057-2019-9-1-16-21
Abstract
Considering a rise in colon cancer rates, searching for new treatment options remains highly relevant for this patient cohort. Determination of chemokine receptors in tumor tissue may become an additional prognostic tool that can be used for planning adjuvant therapy.
About the Authors
R. V. Orlova
Saint Petersburg State University;
Municipal Clinical Oncology Dispensary;
Clinical Hospital No.122 named after L. G. Sokolov of the FMBA of Russia
Russian Federation
Russian Federation
Rashida V. Orlova, MD, PhD, DSc, Professor, Head of the Department of Oncology of the Faculty of Medicine, Saint Petersburg State University, Scientific Consultant, Municipal Clinical Oncology Dispensary, Chief Oncologist of Clinical Hospital No.122 named after L. G. Sokolov of the FMBA of Russia
Saint Petersburg
A. K. Ivanova
Municipal Clinical Oncology Dispensary
Russian Federation
Russian Federation
Anastasia K. Ivanova, oncologist, Department of Chemotherapy
Saint Petersburg
G. A. Raskin
Saint Petersburg State University;
Russian Research Center for Radiology and Surgical Technologies named after Academician A. M. Granov of the Ministry of Health of Russia
Russian Federation
Russian Federation
Grigory A. Raskin, MD, PhD, DSc, Professor of the Department of Oncology of the Faculty of Medicine, FSBEI of Saint Petersburg State University, Head of the Department of Pathology, Russian Research Center for Radiology and Surgical Technologies named after Academician A. M. Granov of the Ministry of Health of Russia
Saint Petersburg
S. I. Kutukova
Municipal Clinical Oncology Dispensary;
First Saint Petersburg State Medical University named after Academician I. P. Pavlov of the Ministry of Health of Russia
Russian Federation
Russian Federation
Svetlana I. Kutukova, MD, PhD, Assistant Professor, Department of Surgical Dentistry, Oral and Maxillofacial Surgery, First Saint Petersburg State Medical University named after Academician I. P. Pavlov of the Ministry of Health of Russia, oncologist of the Department of Chemotherapy of Municipal Clinical Oncology Dispensary
Saint Petersburg
A. V. Androsova
Municipal Clinical Oncology Dispensary
Russian Federation
Russian Federation
Alexandra V. Androsova, oncologist, Department of Chemotherapy
Saint Petersburg
References
1. Каприн А. Д., Старинский В. В., Петрова Г. В. Состояние онкологической помощи населению России в 2016 году, Москва 2017 (стр.157).
2. Мерабишвили В. М. Злокачественные новообразования в северо западном федеральном округе России (заболеваемость, смертность, контингенты, выживаемость больных), выпуск третий под ред. Беляева А. М, СПб,2017, стр.22 32.
3. Journal of Clinical Oncology,27,19, 01.07.2009.
4. D. Sargent ASCO 2014,#3507
5. Практические рекомендации по лечению злокачественных опухолей Российского общества клинической онкологии, версия 2017 (стр.261 264).
6. Expression pattern of CXC chemokine receptor 4 is correlated with lymph node metastasis in human invasive ductal carcinoma. Masahiro Kato, Joji Kitayama, Shinsuke Kazama, Hirokazu Nagawa; Breast Cancer Research, October,2003.
7. Чердынцева Н. В., Гервас П. А., Литвяков Н. В. с соавт. Хемокины и прогрессия злокачественных новообразований. Медицинская Иммунология.–2006. – Т. 8, – № 2 3. – С.355 356.
8. А. С. Симбирцев Цитокины: классификация и биологические функции // Цитокины и воспаление. 2004. Том 3 № 2. – С.16 22.
9. Strieter R. M., Polverini P. J., Kunkel S. L. et al. The functional role of the ELR motif in CXC chemokine mediated angiogenesis. J Biol Chem. 1995. 270 (45): 27348 57.
10. Rivera CG, Bader JS, Popel AS. Angiogenesis associated crosstalk between collagens, CXC chemokines, and thrombospondin domain containing proteins. Ann Biomed Eng. 2011; 39 (8):2213 22.
11. Бережная Н. М., Чехун В. Ф. Иммунология злокачественного роста – 2005
12. Muller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature. 2001; 410:50 56.
13. Zeelenberg IS, Ruuls Van Stalle L, Roos E. The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases. Cancer Res. 2003 Jul 1; 63 (13):3833 9.
14. Sehgal, A., Keener, C., Boynton, AL., Warrick, J., and Murphy, GP. CXCR 4, a chemokine receptor, is overexpressed in and required for proliferation of glioblastoma tumor cells.1998. J. Surg. Oncol. 69, 99 104
15. Uchida D, Begum NM, Almofti A, Nakashiro K, Kawamata H, Tateishi Y, Hamakawa H, Yoshida H, Sato M. Possible role of stromal cellderived factor 1/CXCR4 signaling on lymph node metastasis of oral squamous cell carcinoma. Exp Cell Res 2003. 290: 289 302.
16. Yu X et all J Exp Clin Cancer Res. 2019 Jan 24;38 (1):32. doi: 10.1186/s13046-018-1014-x. CXCL12/CXCR4 promotes inflammation driven colorectal cancer -progression through activation of RhoA signaling by sponging miR 133a 3p.
17. Kim J, Mori T, Chen SL, Amersi FF, Martinez SR, Kuo C, Turner RR, Ye X, Bilchik AJ, Morton DL, Hoon DS. Chemokine receptor CXCR4 expression in patients with melanoma and colorectal cancer liver metastases and the associa tion with disease outcome. Ann Surg. 2006 Jul; 244 (1):113 20.
Review
For citations:
Orlova R.V., Ivanova A.K., Raskin G.A., Kutukova S.I., Androsova A.V. Evaluation of the impact of CXCR4, ССR10 chemokine receptor expression in tumor tissue on relapse free survival in colon cancer patients. Malignant tumours. 2019;9(1):16-21. (In Russ.) https://doi.org/10.18027/2224-5057-2019-9-1-16-21
Views:
822
Email this article 